Huang-Lian-Jie-Du-Decoction modulates glucagon-like peptide-1 secretion in diabetic rats

Journal of Ethnopharmacology

Volumn 124, Issue 3, 2009, Pages 444-449

  Yu, Yun Li ^a   Lu, Shou Si ^a   Yu, Sen ^a   Liu, Yu Chun ^a   Wang, Ping ^a   Xie, Lin ^a   Wang, Guang Ji ^a   Liu, Xiao Dong ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Beta cell; Diabetes; Glucagon like peptide (GLP) 1 (7 36) amide; Huang Lian Jie Du Decoction; L cell; Proglucagon

Indexed keywords

COPTIS CHINENSIS EXTRACT; GARDENIA JASMINOIDES EXTRACT; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; INSULIN; PHELLODENDRON AMURENSE EXTRACT; PROGLUCAGON; SCUTELLARIA BAICALENSIS EXTRACT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DOSE RESPONSE; DRUG MECHANISM; GLUCOSE BLOOD LEVEL; HERBAL MEDICINE; HORMONE RELEASE; INSULIN BLOOD LEVEL; MALE; NONHUMAN; RAT; TREATMENT DURATION;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BLOOD GLUCOSE; BODY WEIGHT; CELL PROLIFERATION; DIABETES MELLITUS, EXPERIMENTAL; DRUGS, CHINESE HERBAL; EATING; GLUCAGON-LIKE PEPTIDE 1; IMMUNOHISTOCHEMISTRY; INDICATORS AND REAGENTS; INSULIN; INSULIN-SECRETING CELLS; INTESTINES; MALE; PANCREAS; PLANT EXTRACTS; PROGLUCAGON; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

RATTUS;

EID: 67650649383     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2009.05.027     Document Type: Article

References (20)

1. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 28 (2005) 37-42
2. Arulmozhi D.K., and Portha B. GLP-1 based therapy for type 2 diabetes. European Journal of Pharmaceutical Sciences 28 (2006) 96-108
3. Baggio L.L., and Drucker D.J. Clinical endocrinology and metabolism. Glucagon-like peptide-1 and glucagon-like peptide-2. Best practice and research. Clinical Endocrinology and Metabolism 18 (2004) 531-554
4. Cani P.D., Daubioul C.A., Reusens B., Remacle C., Catillon G., and Delzenne N.M. Involvement of endogenous glucagons-like peptide-1(7-36) amide on glycaemia-lowering effect of oligofructose in streptozotocin-treated rats. Journal of Endocrinology 185 (2005) 457-465
5. Cani P.D., Dewever C., and Delzenne N.M. Inulin-type fructans modulate gastrointestinal peptides involved in appetite regulation (glucagon-like peptide-1 and ghrelin) in rats. British Journal of Nutrition 92 (2004) 521-526
6. Chen G., Lu F.E., and Xu L.J. Effects of Huanglian Jiedu Decoction on glucose transporter 4 in target tissues of type 2 diabetic rats. Zhong Xi Yi Jie He Xue Bao 5 (2007) 412-415
7. Combettes M.M. GLP-1 and type 2 diabetes: physiology and new clinical advances. Current Opinion in Pharmacology 6 (2006) 598-605
8. Deng Y.X., Liu L., Yu S., Xie L., and Liu X.D. Simultaneous determination of geniposide and 4 flavonoids in the traditional Chinese medicinal preparation Huanglian Jiedu decoction by HPLC with programmed wavelength UV detection. Chinese Journal Pharmaceutical Analysis 28 (2008) 182-186
9. Kong W., Wei J., Abidi P., Lin M., Inaba S., Li C., Wang Y., Wang Z., Si S., Pan H., and Wang S. Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins. Nature Medicine 10 (2004) 1344-1351
10. Liu H., Liu X., Jia L., Liu Y., Yang H., Wang G., and Xie L. Insulin therapy restores impaired function and expression of P-glycoprotein in blood-brain barrier of experimental diabetes. Biochemistry Pharmacology 75 (2008) 1649-1658
11. Liu J., Zheng X., Yin F., Hu Y., Guo L., Deng X., Chen G., Jiajia J., and Zhang H. Neurotrophic property of geniposide for inducing the neuronal differentiation of PC12 cells. International Journal of Developmental Neuroscience 24 (2006) 419-424
12. Lu F.E., Leng S., Tu Q.N., Xu L.J., Yang M.W., and Wang K.F. Comparative study on the effects of Huanglianjiedu decoction and berberine on glucose and lipid metabolism in type 2 diabetic rats. Journal of Huangzhong University of Science and Tecnology [Health Science] 31 (2002) 662-665
13. Lu S.S., Yu Y.L., Zhu H.J., Liu X.D., Liu L., Liu Y.W., Wang P., Xie L., and Wang G.J. Berberine promotes glucagons-like peptide-1 (7-36) amide secretion in streptozotocin-induced diabetic rats. Journal of Endocrinology 200 (2009) 159-165
14. Lu T., Liang Y., Song J., Xie L., Wang G.J., and Liu X.D. Simultaneous determination of berberine and palmatine in rat plasma by HPLC-ESI-MS after oral administration of traditional Chinese medicinal preparation Huang-Lian-Jie-Du decoction and the pharmacokinetic application of the method. Journal of Pharmaceutical and Biomedical Analysis 40 (2006) 1218-1224
15. Meeran K., O'Shea D., Edwards C.M., Turton M.D., Heath M.M., Gunn I., Abusnana S., Rossi M., Small C.J., Goldstone A.P., Taylor G.M., Sunter D., Steere J., Choi S.J., Ghatei M.A., and Bloom S.R. Repeated intracerebroventricular administration of glucagon-like peptide-1-(7-36) amide or exendin-(9-39) alters body weight in the rat. Endocrinology 140 (1999) 244-250
16. Mendieta-Zerón H., López M., and Diéguez C. Gastrointestinal peptides controlling body weight homeostasis. General and Comparative Endocrinology 155 (2008) 481-495
17. Nishioka T., Kawabata J., and Aoyama Y. Baicalein, an alpha-glucosidase inhibitor from Scutellaria baicalensis. Journal of Natural Products 61 (1998) 1413-1415
18. Poon T., Nelson P., Shen L., Mihm M., Taylor K., Fineman M., and Kim D. Exenatide improves glycemic control and reduces body weight in subjects with type 2 diabetes: a dose-ranging study. Diabetes Technology and Therapeutics 7 (2005) 467-477
19. Shen Y.J. Pharmacology of Traditional Chinese Medicine (2000), People's Health Press, Beijing pp. 200-208
20. Stonehouse A., Okerson T., Kendall D., and Maggs D. Emerging incretin based therapies for Type 2 diabetes: incretin mimetics and DPP-4 inhibitors. Current Diabetes Reviews 4 (2008) 101-109